Pregabalin Extended Release Tablet, Film Coated, Extended Release
Product Images NDC 50228-463

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Pregabalin Extended Release (NDC 50228-463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (50 mg/500 mg Tablet Bottle Label)

Label for Pregabalin Extended-Release Tablets 165 mg by ScieGen Pharmaceuticals, Inc. The label indicates a bottle containing 30 tablets, oral extended-release film-coated dosage form. It includes storage instructions and a barcode with the NDC code 50228-463-30.*

FDA Label Image

Principal Display Panel (50 mg/500 mg Tablet Bottle Label)

Label for Pregabalin Extended-Release Tablets 165 mg, oral film-coated tablets by ScieGen Pharmaceuticals, Inc. The label indicates a 500-tablet count with storage instructions at 20°C to 25°C, child-resistant dispensing, and includes a barcode, NDC 50228-463-05, and manufacturer address in Hauppauge, NY. 'Rx Only' and lot/expiration placeholders are present.*

FDA Label Image

Principal Display Panel (50 mg/500 mg Tablet Bottle Label)

Label for Pregabalin Extended-Release Tablets, 330 mg strength, manufactured by ScieGen Pharmaceuticals, Inc. The label states each tablet contains 330 mg pregabalin and includes storage instructions between 20°C to 25°C. The package contains 30 film-coated, extended-release tablets for oral use, marked Rx only. The NDC code 50228-464-30 is visible along with barcodes and lot/expiration placeholders.*

FDA Label Image

Principal Display Panel (50 mg/500 mg Tablet Bottle Label)

Label for Pregabalin Extended-Release Tablets containing 330 mg pregabalin per tablet. The label indicates a package size of 500 tablets and includes storage instructions, dosage and use advisory, barcode, and manufacturing details for ScieGen Pharmaceuticals Inc., Hauppauge, NY. The label notes the product is Rx Only and includes space for lot and expiration information.*

FDA Label Image

Principal Display Panel (50 mg/500 mg Tablet Bottle Label)

Label for Pregabalin Extended Release Tablets 82.5 mg, film-coated oral tablets, supplied as 30 tablets per container. Manufactured by ScieGen Pharmaceuticals, Inc. The label includes storage instructions, dosage reference, and a barcode with NDC 50228-462-30. The label advises dispensing with a medication guide and storing at controlled room temperature.*

FDA Label Image

Principal Display Panel (50 mg/500 mg Tablet Bottle Label)

Label for Pregabalin Extended-Release Tablets 82.5 mg by ScieGen Pharmaceuticals, Inc. The label specifies dosage form as film-coated extended-release tablets with directions to dispense accompanying medication guides. Storage instructions note temperature conditions and child-resistant packaging. The label states 500 tablets, with regulatory and barcode information included.*

FDA Label Image

Principal Display Panel (50 mg/500 mg Tablet Bottle Label)

A formula for calculating creatinine clearance (CLcr) based on age in years, weight in kilograms, serum creatinine in mg/dL, and a multiplier for female patients. This pharmacokinetic parameter is used in clinical assessments related to drug dosing.*

FDA Label Image

Principal Display Panel (50 mg/500 mg Tablet Bottle Label)

A line graph comparing the percent of patients improved versus percent improvement in pain from baseline for Pregabalin Extended Release and placebo. The graph shows two curves, one solid line for Pregabalin and one dashed line for placebo, indicating patient response distribution across varying levels of pain improvement.*

FDA Label Image

Formula (Structure 01)

Chemical structure diagram of pregabalin showing the molecular framework with carboxyl and amino functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.